The Technical Analyst
Select Language :
Navidea [NAVB]

Exchange: AMEX Industry: Biotechnology

Navidea Price, Forecast, Insider, Ratings, Fundamentals & Signals

Navidea is listed at the  Exchange

2.82% $0.0365

America/New_York / 28 mar 2024 @ 15:06


FUNDAMENTALS
MarketCap: 3.65 mill
EPS: -0.200
P/E: -0.180
Earnings Date: Mar 28, 2024
SharesOutstanding: 100.08 mill
Avg Daily Volume: 0.117 mill
RATING 2024-03-28
C+
Sell
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Strong Buy
Return On Asset: Sell
DE: Strong Sell
P/E: Sell
Price To Book: Strong Sell
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/a
Gr.Profitn/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.180 | sector: PE 12.30
PE RATIO: COMPANY / INDUSTRY
0x
Company: PE -0.180 | industry: PE -5.55
DISCOUNTED CASH FLOW VALUE
$-0.0182
(-149.85%) $-0.0547
Date: 2024-03-28
Expected Trading Range (DAY)

$ 0.0275 - 0.0455

( +/- 24.66%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-11-27 Scott John K Jr. Buy 64 289 Series J Convertible Preffered Stock
2023-11-27 Scott John K Jr. Sell 2 270 Series G Redeemable Preferred Stock
2023-11-27 Scott John K Jr. Sell 2 400 Series I Convertible Preferred Stock
2023-11-16 Moss Dana J Buy 416 667 Common Stock
2023-11-16 Moss Dana J Buy 200 000 Common Stock
INSIDER POWER
99.82
Last 95 transactions
Buy: 26 134 406 | Sell: 71 109

Forecast: 16:00 - $0.0365

Live Trading Signals (every 1 min)

Forecast 1: 15:16 - $0.0380
Forecast 2: 16:00 - $0.0365
Forecast 3: 16:00 - $0.0365
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.0365 (2.82% )
Volume 0.0642 mill
Avg. Vol. 0.117 mill
% of Avg. Vol 55.06 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Navidea Biopharmaceuticals Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Navidea Biopharmaceuticals Inc

RSI

Last 10 Buy & Sell Signals For NAVB

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Navidea Biopharmaceuticals Inc

NAVB

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages for a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (PET), gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. It develops NAV3-31, which has completed Phase IIb clinical trials for evaluating imaging repeatability, reproducibility, and stability, as well as the capacity of Tc99m tilmanocept imaging for treatment of anti-tumor necrosis factor alpha therapy in patients with moderate to severe rheumatoid arthritis (RA); NAV3-35 that is in a Phase IIb clinical trial for RA imaging; NAV3-33, which is in Phase III clinical trial for RA; and NAV3-32, which is Phase 2b trial for RA-involved joints. The company is also developing Tc99m tilmanocept for cardiovascular, kaposi's sarcoma, tuberculosis, and other immunotherapeutic applications. The company was formerly known as Neoprobe Corporation and changed its name to Navidea Biopharmaceuticals, Inc. in January 2012. Navidea Biopharmaceuticals, Inc. was incorporated in 1983 and is headquartered in Dublin, Ohio.

Last 10 Buy Signals

Date Signal @
TONUSDMar 28 - 22:084.90
WETHUSDMar 28 - 22:093 569.31
WBETHUSDMar 28 - 22:093 679.41
OMGUSDMar 28 - 22:10$1.094
OETHUSDMar 28 - 22:093 558.64
GALXUSDMar 28 - 22:085.10
ETCUSDMar 28 - 22:10$32.33
AGIUSDMar 28 - 22:090.435
CRVUSDMar 28 - 22:10$0.696
WLDUSDMar 28 - 22:098.33

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.